Ginkgo Financial Statements From 2010 to 2025
| DNA Stock | USD 9.11 1.18 11.47% |
Check Ginkgo Bioworks financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ginkgo Bioworks' main balance sheet or income statement drivers, such as , as well as many indicators such as . Ginkgo financial statements analysis is a perfect complement when working with Ginkgo Bioworks Valuation or Volatility modules.
Ginkgo |
Ginkgo Bioworks Holdings Company Operating Margin Analysis
Ginkgo Bioworks' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Ginkgo Bioworks Operating Margin | (0.59) % |
Most of Ginkgo Bioworks' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ginkgo Bioworks Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Ginkgo Bioworks Holdings has an Operating Margin of -0.5868%. This is 98.33% lower than that of the Biotechnology sector and 99.48% lower than that of the Health Care industry. The operating margin for all United States stocks is 89.35% lower than that of the firm.
Ginkgo Bioworks Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ginkgo Bioworks's current stock value. Our valuation model uses many indicators to compare Ginkgo Bioworks value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ginkgo Bioworks competition to find correlations between indicators driving Ginkgo Bioworks's intrinsic value. More Info.Ginkgo Bioworks Holdings is rated # 2 in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ginkgo Bioworks' earnings, one of the primary drivers of an investment's value.About Ginkgo Bioworks Financial Statements
Ginkgo Bioworks stakeholders use historical fundamental indicators, such as Ginkgo Bioworks' revenue or net income, to determine how well the company is positioned to perform in the future. Although Ginkgo Bioworks investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ginkgo Bioworks' assets and liabilities are reflected in the revenues and expenses on Ginkgo Bioworks' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ginkgo Bioworks Holdings. Please read more on our technical analysis and fundamental analysis pages.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. Ginkgo Bioworks operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 641 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock:Check out the analysis of Ginkgo Bioworks Correlation against competitors. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.